| |
Latest 10 SEC filings (by transaction date) for TCON within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 13/24 | Mar 12/24 | Brown Scott B. | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 224,800 | |
Mar 13/24 | Mar 12/24 | Theuer Charles | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 518,300 | |
Mar 13/24 | Oct 20/23 | Theuer Charles | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 3,500 | $0.133 |
Apr 28/23 | Apr 27/23 | Theuer Charles | Direct Ownership | Common Stock | P - Open market or private purchase | 47,000 | $0.750 |
Apr 28/23 | Apr 26/23 | Theuer Charles | Direct Ownership | Common Stock | P - Open market or private purchase | 3,999 | $0.660 |
Mar 13/24 | Apr 20/23 | Brown Scott B. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 3,500 | $0.138 |
Mar 13/24 | Apr 20/23 | Theuer Charles | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 3,500 | $0.138 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for TCON within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 13/24 | Mar 12/24 | Brown Scott B. | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 224,800 | |
Mar 13/24 | Apr 20/23 | Brown Scott B. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 3,500 | $0.138 |
Mar 13/24 | Mar 12/24 | Theuer Charles | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 518,300 | |
Mar 13/24 | Oct 20/23 | Theuer Charles | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 3,500 | $0.133 |
Mar 13/24 | Apr 20/23 | Theuer Charles | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 3,500 | $0.138 |
Apr 28/23 | Apr 27/23 | Theuer Charles | Direct Ownership | Common Stock | P - Open market or private purchase | 47,000 | $0.750 |
Apr 28/23 | Apr 26/23 | Theuer Charles | Direct Ownership | Common Stock | P - Open market or private purchase | 3,999 | $0.660 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Intra-Cellular Therapies (OQ:ITCI) |
Apellis Pharmaceuticals (OQ:APLS) |
Biomarin Pharmaceutical (OQ:BMRN) |